Profound Medical Corp.
Stock Forecast, Prediction & Price Target
Profound Medical Corp. (PROF) stock Price Target by analysts
$17
Potential upside: 271.17%
Profound Medical Corp. price prediction
What is Profound Medical Corp. stock analysts` prediction?
Profound Medical Corp. stock forecast: Based on 1 Wall Street analysts` predicted price targets for Profound Medical Corp. in the last 3 months, the avarage price target is $17, with a high forecast of $NaN. The average price target represents a 271.17% change from the last price of $4.58.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Profound Medical Corp. stock Price Target by analysts
Full breakdown of analysts given Profound Medical Corp. price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Ben Haynor Loop Capital Markets | 0% 0/1 | 9 months ago | $17 271.17% upside | $8.03 | StreetInsider | Previous targets (0) |
Ben Haynor Lake Street | 0% 0/1 | about 1 year ago | $16.5 260.26% upside | $10.28 | TheFly | Previous targets (0) |
Rick Wise Stifel Nicolaus | 0% 0/1 | about 1 year ago | $12 162.00% upside | $9.15 | StreetInsider | Previous targets (0) |
Profound Medical Corp. Financial Estimates
Profound Medical Corp. Revenue Estimates
Profound Medical Corp. EBITDA Estimates
Profound Medical Corp. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $6.87M N/A | $6.68M -2.79% | $7.19M 7.75% | Avg: $29.70M Low: $18.27M High: $43.45M avg. 312.65% | Avg: $47.47M Low: $34.34M High: $64.87M avg. 59.79% | Avg: $96.67M Low: $69.93M High: $132.12M avg. 103.64% | Avg: $54.82M Low: $39.66M High: $74.93M avg. -43.28% |
Net Income
% change YoY
| $-30.69M N/A | $-28.66M 6.61% | $-28.56M 0.34% | Avg: $-29.51M Low: $-35.30M High: $-26.17M avg. -3.32% | Avg: $-13.71M Low: $-20.25M High: $-8.78M avg. 53.54% | Avg: $20.07M Low: $12.85M High: $29.64M avg. 246.39% | Avg: $-7.91M Low: $-11.69M High: $-5.07M avg. -139.43% |
EBITDA
% change YoY
| $-28.41M N/A | $-25.47M 10.34% | $-26.78M -5.13% | Avg: $-29.70M Low: $-43.45M High: $-18.27M avg. -10.92% | Avg: $-47.47M Low: $-64.87M High: $-34.34M avg. -59.79% | Avg: $-96.67M Low: $-132.12M High: $-69.93M avg. -103.64% | Avg: $-54.82M Low: $-74.93M High: $-39.66M avg. 43.28% |
EPS
% change YoY
| -$1.5 N/A | -$1.38 8.00% | -$1.35 2.17% | Avg: -$1.39 Low: -$1.67 High: -$1.24 avg. -3.22% | Avg: -$0.65 Low: -$0.96 High: -$0.41 avg. 53.54% | Avg: $0.95 Low: $0.61 High: $1.4 avg. 246.39% | Avg: -$0.37 Low: -$0.55 High: -$0.24 avg. -139.43% |
Operating Expenses
% change YoY
| $33.24M N/A | $32.62M -1.86% | $32.99M 1.14% | Avg: $68.20M Low: $41.94M High: $99.76M avg. 106.69% | Avg: $108.98M Low: $78.85M High: $148.95M avg. 59.79% | Avg: $221.94M Low: $160.57M High: $303.33M avg. 103.64% | Avg: $125.88M Low: $91.07M High: $172.04M avg. -43.28% |
FAQ
What is Profound Medical Corp. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 39.29% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -35.30M, average is -29.51M and high is -26.17M.
What is Profound Medical Corp. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 108.20% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $18.27M, average is $29.70M and high is $43.45M.
What is Profound Medical Corp. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 39.31% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.67, average is -$1.39 and high is $-1.23.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Profound Medical Corp. stock. The most successful analyst is Ben Haynor.